Pay in 4 interest-free payments of $5.57 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Most clinical evidence comes from dermatology and wound-healing studies with sample sizes under 100 participants
[7] Comparative studies found BPC-157 was the only compound consistently effective across all acute and chronic GI injury models tested
You go out on the road, you come back home, and you see family
Key Research Areas BPC-157 5mg VEGFR2/ERK1/2 receptor activation and downstream angiogenesis signalling Akt-eNOS nitric oxide pathway and vascular tube formation assays FAK-paxillin pathway fibroblast spreading, migration, and adhesion studies Tendon, ligament, muscle, bone, and skin tissue healing models Anti-inflammatory cytokine modulation TNF-, IL-6 pathway research Gastrointestinal mucosal protection and barrier integrity studies Dose-response research across the full 5mg vial concentration range Key Research Areas TB-500 5mg G-actin sequestration and cytoskeletal reorganisation studies Keratinocyte, endothelial, and stem/progenitor cell migration assays VEGF and actin-binding protein upregulation and angiogenesis initiation Stem and progenitor cell mobilisation and tissue-site differentiation studies Anti-apoptotic signalling and inflammatory cytokine suppression research Cardiac and CNS tissue regeneration pathway studies in pre-clinical models Scar tissue reduction and myofibroblast count modulation research What Do Studies Say About BPC-157 and TB-500
US$ 24.45
US$ 23.56
US$ 25.13
